GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Galderma Group AG (XSWX:GALD) » Definitions » Other Long Term Assets

Galderma Group AG (XSWX:GALD) Other Long Term Assets : CHF213 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Galderma Group AG Other Long Term Assets?

Galderma Group AG's other long-term assets for the quarter that ended in Dec. 2024 was CHF213 Mil.

Galderma Group AG's quarterly other long-term assets declined from Dec. 2023 (CHF237 Mil) to Jun. 2024 (CHF215 Mil) but then stayed the same from Jun. 2024 (CHF215 Mil) to Dec. 2024 (CHF213 Mil).

Galderma Group AG's annual other long-term assets increased from . 20 (CHF0 Mil) to Dec. 2023 (CHF237 Mil) but then declined from Dec. 2023 (CHF237 Mil) to Dec. 2024 (CHF213 Mil).

Galderma Group AG Other Long Term Assets Historical Data

The historical data trend for Galderma Group AG's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galderma Group AG Other Long Term Assets Chart

Galderma Group AG Annual Data
Trend Dec23 Dec24
Other Long Term Assets
236.96 213.09

Galderma Group AG Semi-Annual Data
Jun23 Dec23 Jun24 Dec24
Other Long Term Assets - 236.96 214.51 213.09

Galderma Group AG Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Galderma Group AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Galderma Group AG (XSWX:GALD) » Definitions » Other Long Term Assets
Comparable Companies
XSWX:SDZ XSWX:PPGN XSWX:SFZN XSWX:CURN ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN NSE:DIVISLAB HKSE:03692 XTAE:TEVA SHSE:688506 BOM:500087 TSE:4507 SZSE:000538 UTHR NSE:TORNTPHARM BOM:543904 BOM:500124
Traded in Other Exchanges
GALDY:USA GDERF:USA GALDz:UK PY30:Germany
Address
Zahlerweg 10, Zug, CHE, 6300
Website
https://www.galderma.com
Galderma was formed in 1981 as a joint venture between Nestle and L'Oreal. It subsequently became a subsidiary of Nestle, called Nestle Skin Health, before being carved out and launched as a standalone company in 2019, acquired by a consortium led by Sweden-based EQT fund. The company went public in March 2024 and is listed on the SIX Swiss exchange. Galderma's science-based portfolio spans multiple dermatology categories, including injectable aesthetics, dermatological skincare, and therapeutic dermatology. It derives around 45% of net sales from the US and employs around 6,600 people.

Galderma Group AG Headlines

No Headlines